Upstate Active Clinical Trials
Study Title:A study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ RSV investigational vaccine based on viral proteins encoded by chimpanzee-derived adenovector (ChAd155-RSV)(GSK3389245A) in RSV-seropositive infants.
What is the purpose of the study?The study will try to find out if the study vaccine against a germ called RSV (respiratory syncytial virus) is safe and may protect against this disease.
Upstate Institutional Review Board (IRB) Number:939407
Study/Protocol ID:204838 (RSV PED-002)
Study Phase:Phase 1/2
Patient Age Group:Children
Principal Investigator:Joseph B Domachowske
Who can I contact for more information?
Name: Lori J Ferguson